Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
SHZ: 002932.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Chen Li Li
- Employees
- 1,063
- Headquarters
- Wuhan, China
- IPO year
- 2018
- Market cap
- CN¥4.0B
- Website
- https://www.mdeasydiagnosis.com
Loading 002932…
Loading profile data…Frequently asked questions about 002932
What does Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ) do?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunod...
Where does 002932.SZ trade?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002932.SZ in?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Wuhan Easy Diagnosis Biomedicine Co.,Ltd.?
Chen Li Li is the chief executive officer of Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ).
Where is Wuhan Easy Diagnosis Biomedicine Co.,Ltd. headquartered?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. is headquartered in China.
Does 002932.SZ pay a dividend?
Yes — Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ) paid a trailing twelve-month dividend of CNY 1.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002932.SZ go public?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ) completed its initial public offering in 2018.